summary
Introduced
02/02/2026
02/02/2026
In Committee
02/02/2026
02/02/2026
Crossed Over
Passed
Dead
Introduced Session
2026-2027 Regular Session
Bill Summary
This bill requires health insurers (health, hospital and medical service corporations; commercial individual and group health insurers; health maintenance organizations; health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs; the State Health Benefits Program; and the School Employees' Health Benefits Program) to provide coverage for expenses incurred in the treatment of Lyme Disease. Treatment otherwise eligible for benefits pursuant to this bill may not be denied solely because such treatment may be characterized as experimental or investigational in nature.
AI Summary
This bill mandates that various health insurers, including hospital and medical service corporations, commercial individual and group health insurers, health maintenance organizations (HMOs), and state-administered health plans like the State Health Benefits Program and the School Employees' Health Benefits Program, must cover expenses for Lyme disease treatment. This coverage applies to treatments deemed medically necessary by a physician after a written evaluation of the patient's condition, and importantly, insurers cannot deny coverage simply because a treatment is considered experimental or investigational. The bill aims to ensure that individuals diagnosed with Lyme disease receive necessary medical care without facing insurance barriers related to the nature of the treatment.
Committee Categories
Business and Industry
Sponsors (1)
Last Action
Introduced in the Senate, Referred to Senate Commerce Committee (on 02/02/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2026/S3262 |
| BillText | https://pub.njleg.gov/Bills/2026/S3500/3262_I1.HTM |
Loading...